Frederick L. Locke, MD, discussed cema-cel's safety, efficacy, and potential for treating large B-cell lymphoma in earlier ...

It’s more common in older adults, people with weakened immune systems, and people with primary CNS lymphoma. There are two main types of lymphocytes, called B cells and T cells. But the kind ...

Researchers Uncover Mechanism That Fuels Growth of Aggressive B-Cell Lymphoma June 18 ... Details About Rare Second Cancers Related to CAR-T Therapy June 12, 2024 — A new detailed analysis ...

A rare case has been reported of diffuse large B-cell lymphoma (DLBCL) presenting initially as cold agglutinin disease (CAD). The report, published in the Kaohsiung Journal of Medical Sciences, ...

Corvus Pharmaceuticals reported positive Phase 1/1b trial data for soquelitinib in T cell lymphoma, showing significant anti-tumor activity. Corvus Pharmaceuticals, Inc. announced new findings ...

FDA grants fast track designation to azer-cel, an allogeneic CAR T-cell therapy, for relapsed or refractory diffuse large ...

LUND, SE / ACCESS Newswire / March 21, 2025 / BioInvent International AB ("BioInvent") (Nasdaq Stockholm:BINV), a biotech ...

Finding God has been the answer for Olivia Anderson, 46, a Norfolkan who has been fighting an ongoing battle with lymphoma ...

Data incorporated for this study were collected from 9 centers in the UK focused on third-line and beyond chimeric antigen ...

T-cell lymphoma is a rare cancer that develops in T cells, a type of white blood cell that helps the immune system. Twenty five patients were enrolled in the study. Out of this, 9 patients (39% ...

Expansion cohorts include ovarian cancer, all tumor types and T-cell lymphoma (including CTCL). The dose escalation in Phase 1 part B has been completed and the Phase 2a dose expansion study for ...